脑肿瘤放射外科与开放手术的医师报销及手术量趋势:2009至2018年Medicare数据分析
该研究利用2009至2018年Medicare公开数据,分析颅内肿瘤开放切除与立体定向放射外科(SRS)的手术量及医师报销趋势。结果显示SRS治疗量显著增加而开放切除略降,神经外科医生参与SRS的比例下降,且SRS每次治疗的平均医师报销高于开放切除。
要点
- 2009至2018年Medicare参保者中SRS治疗量每年增加3.97例/10万人,开放切除每年减少0.34例/10万人。
- 2018年SRS治疗量为开放切除的2.6倍(74.9 vs 28.7例/10万人)。
- 神经外科医生参与SRS的比例从23.4%降至11.5%,每次SRS治疗 lesions 数从1.46增至1.84。
核心结论
- 十年间Medicare参保者颅内肿瘤开放切除量略降,SRS治疗量大幅增加。
- SRS增长主要归因于放射肿瘤医生,神经外科医生参与SRS转向多病灶治疗。
研究设计与样本
- 基于2009至2018年Medicare Part B全国汇总数据,识别10个开放切除编码和9个SRS编码(4个神经外科、5个放射肿瘤)。
- 分析每10万参保者手术量及每次手术报销,采用线性回归、斜率相等检验、t检验及ANOVA事后Tukey HSD检验(α=0.05)。
主要发现
- SRS治疗量每年增加3.97例/10万人(R²=0.99,p<0.001),开放切除每年减少0.34例/10万人(R²=0.85,p<0.001),斜率差异显著(t16=7.5,p<0.001)。
- 2018年SRS治疗量为开放切除的2.6倍(74.9 vs 28.7例/10万人)。
- 神经外科医生参与SRS比例从23.4%降至11.5%,每次SRS治疗病灶数从1.46增至1.84(R²=0.98,p<0.001)。
- 2013至2018年SRS平均医师报销$1816.08(95%CI $1788.71-$1843.44),开放切除$1565.59(95%CI $1535.83-$1595.34),差异显著(t10=15.9,p<0.001)。
- 神经外科医生开放切除平均报销$1566,SRS每次$1031-$1198;放射肿瘤医生SRS每次$359-$898(Tukey HSD所有比较p<0.05)。
临床怎么用
- 神经外科医生在SRS中的角色正转向多病灶治疗,需关注其在多学科团队中的定位与报销模式。
- SRS治疗量增长主要由放射肿瘤医生驱动,神经外科参与度下降可能影响培训与学科发展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Given its minimally invasive nature and effectiveness, stereotactic radiosurgery (SRS) has become a mainstay for the multimodal treatment of intracranial neoplasm. However, no studies have evaluated recent trends in the use of SRS versus those of open resection for the management of brain tumor or trends in the involvement of neurosurgeons in SRS (which is primarily delivered by radiation oncologists). Here, the authors used publicly available Medicare data from 2009 to 2018 to elucidate trends in the treatment of intracranial neoplasm and to compare reimbursements between these approaches. METHODS: By using CPT Professional 2019, the authors identified 10 open resection and 9 SRS codes (4 for neurosurgery and 5 for radiation oncology) for the treatment of intracranial neoplasm. Medicare payments (inflation adjusted) and allowed services (number of reimbursed procedures) for each code were abstracted from the Centers for Medicare and Medicaid Services Part B National Summary Data File (2009-2018). Payments per procedure and procedures per 100,000 Medicare enrollees were analyzed with linear regression and compared with tests for equality of slopes (α = 0.05). The average payment per procedure over the study period was compared by using the 2-tailed Welsh unequal variances t-test, and more granular comparisons were conducted by using ANOVA with post hoc Tukey honestly significant difference (HSD) tests. RESULTS: From 2009 to 2018, the number of SRS treatments per 100,000 Medicare enrollees for intracranial neoplasm increased by 3.97 cases/year (R2 = 0.99, p < 0.001), while comparable open resections decreased by 0.34 cases/year (R2 = 0.85, p < 0.001) (t16 = 7.5, p < 0.001). By 2018, 2.6 times more SRS treatments were performed per 100,000 enrollees than open resections (74.9 vs 28.7 procedures). However, neurosurgeon involvement in SRS treatment declined over the study period, from 23.4% to 11.5% of SRS treatments; simultaneously, the number of lesions treated per session increased from 1.46 to 1.84 (R2 = 0.98, p < 0.001). Overall, physician payments from 2013 to 2018 averaged $1816.08 (95% CI $1788.71-$1843.44) per SRS treatment and $1565.59 (95% CI $1535.83-$1595.34) per open resection (t10 = 15.9, p < 0.001). For neurosurgeons specifically, reimbursements averaged $1566 per open resection, but this decreased to $1031-$1198 per SRS session; comparatively, radiation oncologists were reimbursed even less (average $359-$898) per SRS session (p < 0.05 according to the Tukey HSD test for all comparisons). CONCLUSIONS: Over a decade, the number of open resections for intracranial neoplasm in Medicare enrollees declined slightly, while the number of SRS procedures increased greatly. This latter expansion is largely attributable to radiation oncologists; meanwhile, neurosurgeons have shifted their involvement in SRS toward sessions for the management of multiple lesions.
引用
- Lad M, Gupta R, Raman A, et al. Trends in physician reimbursements and procedural volumes for radiosurgery versus open surgery in brain tumor care: an analysis of Medicare data from 2009 to 2018. J Neurosurg. 2021. PMID: 34330094. doi:10.3171/2020.11.JNS202284
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。